A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Measuring RAN Peptide Toxicity in C. elegans

6.2K views

⸱

DOI:

10.3791/61024

⸱

April 30th, 2020

 ,  ,  , 

In This Article

Summary

Repeat-associated non-ATG-dependent translational products are emerging pathogenic features of several repeat expansion-based diseases. The goal of the protocol described is to evaluate toxicity caused by these peptides using behavioral and cellular assays in the model system C. elegans.

Abstract

C. elegans is commonly used to model age-related neurodegenerative diseases caused by repeat expansion mutations, such as Amyotrophic Lateral Sclerosis (ALS) and Huntington’s disease. Recently, repeat expansion-containing RNA was shown to be the substrate for a novel type of protein translation called repeat-associated non-AUG-dependent (RAN) translation. Unlike canonical translation, RAN translation does not require a start codon and only occurs when repeats exceed a threshold length. Because there is no start codon to determine the reading frame, RAN translation occurs in all reading frames from both sense and antisense RNA templates that contain a repeat expansion sequence. Therefore, RAN translation expands the number of possible disease-associated toxic peptides from one to six. Thus far, RAN translation has been documented in eight different repeat expansion-based neurodegenerative and neuromuscular diseases. In each case, deciphering which RAN products are toxic, as well as their mechanisms of toxicity, is a critical step towards understanding how these peptides contribute to disease pathophysiology. In this paper, we present strategies to measure the toxicity of RAN peptides in the model system C. elegans. First, we describe procedures for measuring RAN peptide toxicity on the growth and motility of developing C. elegans. Second, we detail an assay for measuring postdevelopmental, age-dependent effects of RAN peptides on motility. Finally, we describe a neurotoxicity assay for evaluating the effects of RAN peptides on neuron morphology. These assays provide a broad assessment of RAN peptide toxicity and may be useful for performing large-scale genetic or small molecule screens to identify disease mechanisms or therapies.

Introduction

The inappropriate expansion of DNA repeat sequences is the genetic basis for several neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and Huntington’s disease (HD)1. While there are established cellular and animal models for these diseases, mechanisms underlying these conditions are not well defined. For example, HD is caused by the expansions of a CAG repeat sequence in the coding sequence for the Huntingtin protein Htt2. Because CAG encodes the amino acid glutamine, the CAG repeat expansion results in the insertion of a polyGlutamine, or polyQ, sequence within....

Access restricted. Please log in or start a trial to view this content.

Protocol

1. Generating codon-varied RAN peptide expression constructs

  1. Design the individual RAN peptide coding sequence utilizing synonymous codons to eliminate the fundamental repetitive DNA/RNA structure but preserve the overlying amino acid sequence.
  2. Order the custom codon sequences commercially at the repeat lengths needed for the studies (typically 5–100 repeats). Include a HindIII restriction site at the 5' end and a BamHI restriction site at the 3' end to facilitate cloning into C. elegans expression vectors, such as pPD95.79.
    NOTE: If synthesis of larger constructs proves difficult, smaller building block sequences ca....

Access restricted. Please log in or start a trial to view this content.

Results

We used the assays described here to evaluate the effect of different gene inhibitions on the toxicity of RAN dipeptides that are found in ALS patients with a G4C2 repeat expansion. Using the growth assay to measure developmental toxicity, we analyzed the effects of several genetic knockout mutants identified in a genome-wide RNAi screen suppressors of muscle-expressed PR50-GFP toxicity. While expression of PR50-GFP alone resulted in a completely penetrant growth arrest, loss of function mutations i.......

Access restricted. Please log in or start a trial to view this content.

Discussion

Here we report methods that can be used to assay RAN peptide toxicity modeled in the muscle or in the neurons of C. elegans. While neurodegenerative proteins have an age onset phenotype in human patients, they can also exhibit developmentally toxicity when overexpressed in model systems. Overexpression has significant interpretive limitations, but it also provides a powerful starting point for genetic or pharmacological screens aimed at identifying genes or drugs that can reverse toxic phenotypes. This is especi.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

NIH R21NS107797

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
35mm x 10mm Petri Dish, SterileCELLTREAT Scientific Products50-202-036Nematode growth plates and RNAi
AGAR GRANULATED 2KILOGRAMBD DIAGNOSTIC SYSTEMSDF0145070Nematode growth plates and RNAi
AGAROSE ULTRAPURELIFE TECHNOLOGIES16500500Microinjection to generate RAN peptide transgenic strains
CARBENICILLIN 5GTHERMO SCI FAIRLAWN CHEMICALSBP26485Nematode growth plates and RNAi
COVER GLASSES NO 1 22MM 1OZ/PKTHERMO SCI ERIE12542BImaging for commissure assay
FEMOTIPS DISPSBL MICROINJ 20CSEPPENDORF NORTH AMERICA BIOTOOLSE5242952008Microinjection to generate RAN peptide transgenic strains
FF COV GLASS NO1 40X22MM 1OZPKTHERMO SCI ERIE125485CMicroinjection to generate RAN peptide transgenic strains
Fisherbrand Superfrost Plus Microscope SlidesTHERMO SCI ERIE12-550-15Imaging for commissure assay
Gibco Bacto Peptone Gibco DF0118-17-0Nematode growth plates and RNAi
HALOCARBON OIL 700SIGMA-ALDRICH INCH8898-50MLMicroinjection to generate RAN peptide transgenic strains
IPTG BIOTECH 10GTHERMO SCI FAIRLAWN CHEMICALSBP162010Nematode growth plates and RNAi
Leica Advanced Fluorescence imaging softwareLeica MicrosystemsLAS-AFImage acquisition software for video speed analysis and commissure assay
Leica Immersion type N (Oil)W NUHSBAUM INCNC9547002Imaging for commissure assay
LEVAMISOLE HYDROCHLORIDE 10GRTHERMO SCI ACROS ORGANICSAC187870100Imaging for commissure assay
MICROLOADER TIPS 2 X 96 PCSEPPENDORF NORTH AMERICA BIOTOOLSE5242956003Microinjection to generate RAN peptide transgenic strains

PETRI DISH, 60X15MM,500/CS
CORNING LIFE SCIENCES PLASTICFB0875713ANematode growth plates and RNAi
TISSUE CULT PLATE 24WEL 50/CSCORNING LIFE SCIENCES DL87721Nematode growth plates and RNAi

References

  1. Cleary, J. D., Ranum, L. P. Repeat associated non-ATG (RAN) translation: new starts in microsatellite expansion disorders. Current Opinion in Genetics and Development. 26, 6-15 (2014).
  2. The Huntington's Disease Collaborative Research Group.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

C elegans ModelRepeat Expansion DisordersVideo Speed AnalysisAge Dependent Paralysis AssayNeuron Morphology AssayRNAi ScreeningProteasome Subunit RPN7Insulin IGF Receptor DAF-2Commissure Assay